Blake Irving
Known title: DirectorCIK: 0001492275
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADSK Growth Trajectory and Market Pullback in Focus. Recent news highlights Autodesk's market pullback and debates over whether it remains a top play on fast software growth. Articles compare its cloud and AI investments to peers like Adobe and PTC, questioning future earnings acceleration. This divided outlook is reflected in analyst targets spanning $215.00 to $375.00, as the stock trades within its $185.50 to $320.00 range.
Transaction History
| DOCU | ▲ Buy | Option Exercise | 1,096 | $0 | 9/1/2026 | View on chart |
| ADSK | ▲ Buy | Grant | 559 | $0 | 6/17/2026 | View on chart |
| ADSK | ▲ Buy | Grant | 1,553 | $0 | 6/17/2026 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 32,997 | $0 | 6/9/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 5/29/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 2/28/2026 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 11/29/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 729 | $0 | 8/29/2025 | View on chart |
| ADSK | ▲ Buy | Grant | 345 | $0 | 6/18/2025 | View on chart |
| ADSK | ▲ Buy | Grant | 846 | $0 | 6/18/2025 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 20,429 | $0 | 6/10/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,069 | $0 | 5/29/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 2/28/2025 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 11/29/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 1,068 | $0 | 8/29/2024 | View on chart |
| ADSK | ▲ Buy | Grant | 354 | $0 | 7/16/2024 | View on chart |
| ADSK | ▲ Buy | Grant | 984 | $0 | 7/16/2024 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 12,422 | $0 | 6/11/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 998 | $0 | 5/29/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 2/29/2024 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 11/30/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 997 | $0 | 8/31/2023 | View on chart |
| ADSK | ▲ Buy | Grant | 432 | $0 | 6/21/2023 | View on chart |
| ADSK | ▲ Buy | Grant | 1,202 | $0 | 6/21/2023 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 8,495 | $0 | 6/13/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 672 | $0 | 5/31/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 3/3/2023 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 12/3/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 671 | $0 | 9/3/2022 | View on chart |
| ADSK | ▲ Buy | Grant | 547 | $0 | 6/16/2022 | View on chart |
| ADSK | ▲ Buy | Grant | 1,521 | $0 | 6/16/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 5/28/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 2/28/2022 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 279 | $0 | 11/28/2021 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 492 | $0 | 8/29/2021 | View on chart |
| DOCU | ▲ Buy | Option Exercise | 278 | $0 | 8/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
DocuSign Quotation Resumes After Trading Halt
DocuSign shares resumed trading after a brief halt, marking the release of the security for quotation. This event coincides with broader positive momentum in the software sector, where peers like FactSet reported strong earnings and EPAM announced a significant share repurchase. Analysts currently hold an average price target of $69.99 for the stock.
DocuSign Quotation Resumes After Trading Halt. DocuSign shares resumed trading after a brief halt, marking the release of the security for quotation. This event coincides with broader positive momentum in the software sector, where peers like FactSet reported strong earnings and EPAM announced a significant share repurchase. Analysts currently hold an average price target of $69.99 for the stock.